Carregant...
Dexmedetomidine to Control Agitation and Delirium from Toxic Ingestions in Adolescents
Dexmedetomidine is an α(2)-adrenergic agonist that is approved by the Food and Drug Administration for the provision of short term (less than 24 hours) sedation of adults during mechanical ventilation. Given its beneficial physiologic effects including sedation and anxiolysis, various applications h...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pediatric Pharmacy Advocacy Group
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3017407/ https://ncbi.nlm.nih.gov/pubmed/22477792 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|